Uchimura K - Search Results

1

Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells.

Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, Iwamoto H, Nawata H. Uchimura K, et al. Hepatology. 2001 Jan;33(1):91-9. doi: 10.1053/jhep.2001.21145. Hepatology. 2001. PMID: 11124825

2

Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells.

Kato M, Iwamoto H, Higashi N, Sugimoto R, Uchimura K, Tada S, Sakai H, Nakamuta M, Nawata H. Kato M, et al. Among authors: uchimura k. J Hepatol. 1999 Jul;31(1):91-9. doi: 10.1016/s0168-8278(99)80168-8. J Hepatol. 1999. PMID: 10424288

3

Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of jun-N-terminal kinase and the NF-kappab signaling pathway in rat Kupffer cells.

Shimohashi N, Nakamuta M, Uchimura K, Sugimoto R, Iwamoto H, Enjoji M, Nawata H. Shimohashi N, et al. Among authors: uchimura k. J Cell Biochem. 2000 Jun 12;78(4):595-606. J Cell Biochem. 2000. PMID: 10861857

4

Kinetics of the hepatitis C virus during interferon therapy as a marker of therapeutic response.

Nakamuta M, Fukutomi T, Shimohashi N, Kinukawa N, Uchimura K, Tada S, Motomura K, Enjoji M, Kato M, Iwamoto H, Tanabe Y, Imari Y, Sakamoto S, Sakai H, Nawata H. Nakamuta M, et al. Among authors: uchimura k. J Gastroenterol Hepatol. 2001 Jan;16(1):29-33. doi: 10.1046/j.1440-1746.2001.02390.x. J Gastroenterol Hepatol. 2001. PMID: 11206312

5

Serum levels of HCV RNA and core protein before and after incubation at 37 degrees C for 24 h.

Nakamuta M, Shimohashi N, Tada S, Kinukawa N, Enjoji M, Uchimura K, Motomura K, Sugimoto R, Kato M, Iwamoto H, Kuniyoshi M, Sakai H, Nawata H. Nakamuta M, et al. Among authors: uchimura k. Hepatol Res. 2001 Mar 26;19(3):254-262. doi: 10.1016/s1386-6346(00)00115-7. Hepatol Res. 2001. PMID: 11251308

6

Hepatic epithelioid hemangioendothelioma.

Uchimura K, Nakamuta M, Osoegawa M, Takeaki S, Nishi H, Iwamoto H, Enjoji M, Nawata H. Uchimura K, et al. J Clin Gastroenterol. 2001 May-Jun;32(5):431-4. doi: 10.1097/00004836-200105000-00015. J Clin Gastroenterol. 2001. PMID: 11319317 Review.

7

Serum leptin levels in patients with nonalcoholic chronic liver disease.

Nakamuta M, Tada S, Uchimura K, Enjoji M, Kinukawa N, Iwamoto H, Sugimoto R, Shimada M, Ohashi M, Sugimachi K, Nawata H. Nakamuta M, et al. Among authors: uchimura k. Hepatogastroenterology. 2001 Mar-Apr;48(38):527-32. Hepatogastroenterology. 2001. PMID: 11379347

8

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study.

Sugimoto R, Satoh T, Ueda A, Senju T, Tanaka Y, Yamashita S, Koyanagi T, Kurashige T, Higuchi N, Nakamura T, Tanaka M, Azuma Y, Ohno A, Ooho A, Ooe M, Mutsuki T, Uchimura K, Kuniyoshi M, Tada S, Aratake Y, Yoshimoto T, Yamashita N, Harada S, Nakamuta M, Motomura K, Kohjima M; Liver disease Investigators’ Network of Kyushu University & Surrounding Hospitals (LINKS). Sugimoto R, et al. Among authors: uchimura k. Medicine (Baltimore). 2022 Oct 7;101(40):e30871. doi: 10.1097/MD.0000000000030871. Medicine (Baltimore). 2022. PMID: 36221372 Free PMC article.

9

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma.

Sugimoto R, Motomura K, Ooho A, Aratake Y, Ueda A, Senju T, Tanaka Y, Yada M, Tanaka K, Kuwano A, Morita Y, Nagasawa S, Ooe M, Mutsuki T, Yoshimoto T, Yamashita N, Nakashima M, Hioki T, Koyanagi T, Higuchi N, Nakamura T, Harada S, Tanaka M, Tada S, Satoh T, Uchimura K, Kuniyoshi M, Nakamuta M, Kohjima M; Liver Disease Investigators' Network of Kyushu University & Surrounding Hospitals (LINKS). Sugimoto R, et al. Among authors: uchimura k. Intern Med. 2022;61(21):3157-3164. doi: 10.2169/internalmedicine.9237-21. Epub 2022 Nov 1. Intern Med. 2022. PMID: 36328582 Free PMC article.

10

Case Report: haemothorax due to hepatocellular carcinoma rupture successfully controlled by transcatheter arterial embolization.

Masumoto A, Motomura K, Uchimura K, Morotomi I, Morita K. Masumoto A, et al. Among authors: uchimura k. J Gastroenterol Hepatol. 1997 Feb;12(2):156-8. doi: 10.1111/j.1440-1746.1997.tb00399.x. J Gastroenterol Hepatol. 1997. PMID: 9083917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters